Viewing Study NCT03087032

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 9:40 PM
Ignite Modification Date: 2026-02-21 @ 10:19 PM
Study NCT ID: NCT03087032
Status: RECRUITING
Last Update Posted: 2025-01-13
First Post: 2017-03-08
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Liraglutide-bolus vs Glargine-bolus Therapy in Overweight/Obese Type 2 Diabetes Patients (LiraGooD)
Sponsor: The First Affiliated Hospital of Xiamen University
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Type 2 Diabetes Patients View
None Overweight and Obesity View
None Hyperglycaemia (Diabetic) View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Liraglutide View
None Insulin Glargine View
None Prandial Insulin View